The Dermatology Digest

FEBRUARY 8, 2024

Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

Aesthetic Advancements Institute (AAI)

JUNE 20, 2023

There is a new dermal filler on the market! Juvéderm’s® newest filler, Volux , has been approved by the FDA and is set to hit medical offices in early 2023. This new filler is designed to specifically target the jawline, an area of concern for many consumers seeking facial sculpting and contouring.

Training 36

Training Injections Medical Facials 36

The Dermatology Digest

AUGUST 30, 2023

Ted Lain, MD, MBA, board-certified dermatologist and Chief Medical Officer, Sanova Dermatology, Austin, Texas. More frequent patient office visits can also be better for the practice because of the opportunity to discuss other products or procedures, he said. “I But maybe it just takes some time for that to mature in the market.”

Wrinkles 36

Wrinkles Office Safety Clinic 36

The Dermatology Digest

MARCH 6, 2024

Benzoyl Peroxide-based acne medications can become unstable and form benzene, a known human carcinogen, according to new research from Valisure, an independent laboratory focused on testing the purity and safety of pharmaceutical drugs and consumer products. Food and Drug Administration (FDA).

Sanitation 36

Sanitation Pharmaceutical Marketing Safety 36

The Dermatology Digest

FEBRUARY 5, 2024

“Through our innovative device and technologies, we are confident that Trufacial customers will experience the optimal at-home skincare to address their individual cosmetic concerns and maintain favorable outcomes from in-office treatments.” Perfect Corp. Expands AI Skin Simulation Technology Perfect Corp.

Dermatology 36

Dermatology Pharmaceutical Technology Sales 36

Aesthetics Advisor

AUGUST 17, 2023

I recently met again with a consortium of federal agencies, the Office of Assistant Secretary of Health, the Environmental Protection Agency, the White House Council of Environmental Quality, to make the push to implement what the Food and Drug Administration has already said, which is to end amalgam for children and pregnant women.

Safety 36

Safety Sales Marketing Training 36

Aesthetics Advisor

JUNE 3, 2024

Both drugs come from the Danish pharmaceutical company Novo Nordisk, whose market capitalization has soared to $609 billion, surpassing Tesla’s valuation by $40 billion. According to an article by the American Society of Plastic Surgeons: 15 "A new trend is taking shape in the offices of many plastic surgeons.

Surgery 36

Surgery Diet Pharmaceutical Medical 36

The Dermatology Digest

APRIL 23, 2024

The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.

Marketing 36

Marketing Safety Clinic Sustainability 36

Aesthetics Advisor

JANUARY 22, 2024

milligrams per day, slightly less than the recommendation, according to the Office of Dietary Supplements. While there are several chelated zinc supplements on the market, one of the best options is NOW Foods’ Zinc Glycinate softgels. Zinc dosage for senior: Men over age 60 do not usually meet their recommended daily zinc needs.

Vitamin C 36

Vitamin C Diet Branding Ingredients 36

The Dermatology Digest

FEBRUARY 26, 2024

Marketing Authorization Application. About the MIRA trial The MIRA trial (M1095-HS-201) is a global, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Nanobody sonelokimab, administered subcutaneously, in the treatment of adult patients with active moderate-to-severe hidradenitis suppurativa.

Office 74

Office Safety Innovations Clinic 74

Art of Dermatology

SEPTEMBER 6, 2023

Everyone from hotels to oil companies has participated in greenwashed marketing. When fraudulent, deceptive, or even just exaggerated environmental, health, and safety claims are made in the marketing of a product, that’s greenwashing. What is Greenwashing? Greenwashing is not a new tactic.

Branding 36

Branding Skincare Brands Skincare Ingredients 36

The Dermatology Digest

MAY 15, 2024

seeking Food and Drug Administration approval for the use of YCANTH for the treatment of common warts, but may also be utilized by Verrica to seek future marketing authorizations in territories outside the U.S. and Japan, including potentially within the European Union.”

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

The Beauty Brains

MARCH 4, 2019

They also have advice from a body called the scientific committee for cosmetic safety or SCCS, which is composed largely of academics with an interest in medicine and general science. This is a simply enormous database of every cosmetic formulation on the market along with its pack copy. Smaller producers? Not so much.

Safety 52

Safety Cosmetic Products Pharmaceutical Ingredients 52

Aesthetics Advisor

JUNE 16, 2024

But the authors also noted that “further studies are needed to assess the long-term efficacy and safety of this technique.” Says Dr. Hartman, the lack of safety data and FDA approval are what make exosomes in serums and creams such a contentious trend. freeze) them. Hartman refers to exosomes as "the AI of skin care."

Aromatherapy 36

Aromatherapy Injections Ingredients Moisturization 36

Aesthetics Advisor

AUGUST 18, 2023

Kanter will perform many of these tests at her office, and helps patients customize their diet. We're also seeing complete cleaning of the dentinal tubules … down to the microtubules as well … There's one more technology on the market that's reaching a lot of endodontists.

Extractions 36

Extractions Technology Therapy Treatments 36

First Derm

MARCH 10, 2021

Liu and Bui go on to conclude their study with a fair assessment of our growing market. Both teams say that the model neural network looks promising, however, more rigorous assessments of its safety would need to be made before such a program could go public. Says Ann Zyto, Chief Executive Officer at Medicoo. “We

Hospital 40

Hospital Technology Clinic Training 40

Aesthetics Advisor

SEPTEMBER 15, 2023

It’s pure commonsense ,” Nathan Jones, chief executive officer of Xlear said in a statement. The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades. There is a growing body of data that sprays, in particular Xlear, can help combat the COVID-19 pandemic. the South-African or B.1.351,

Hospital 69

Hospital Clinic Marketing Medical 69